切换至 "中华医学电子期刊资源库"

中华疝和腹壁外科杂志(电子版) ›› 2020, Vol. 14 ›› Issue (04) : 331 -335. doi: 10.3877/cma.j.issn.1674-392X.2020.04.003

所属专题: 文献

综述

胃食管反流病的非药物治疗研究进展
魏雪1, 卢迪1, 郝建宇1,()   
  1. 1. 100020 首都医科大学附属北京朝阳医院消化内科
  • 收稿日期:2020-04-02 出版日期:2020-08-18
  • 通信作者: 郝建宇
  • 基金资助:
    北京市科技计划首都临床特色应用研究与成果推广(Z171100001017054)

New progress in non-drug therapy for gastroesophageal reflux disease

Xue Wei1, Di Lu1, Jianyu Hao1,()   

  1. 1. Department of Gastroenterology, Beijing Chaoyang Hospital, Capital Medical University, Chaoyang District, Beijing 100020, China
  • Received:2020-04-02 Published:2020-08-18
  • Corresponding author: Jianyu Hao
  • About author:
    Corresponding author: Hao Jianyu, Email:
引用本文:

魏雪, 卢迪, 郝建宇. 胃食管反流病的非药物治疗研究进展[J/OL]. 中华疝和腹壁外科杂志(电子版), 2020, 14(04): 331-335.

Xue Wei, Di Lu, Jianyu Hao. New progress in non-drug therapy for gastroesophageal reflux disease[J/OL]. Chinese Journal of Hernia and Abdominal Wall Surgery(Electronic Edition), 2020, 14(04): 331-335.

胃食管反流病是消化系统常见疾病,其主要治疗方法为质子泵抑制剂等药物治疗。但质子泵抑制剂等药物治疗存在一定局限性,因此随着内镜及腹腔镜技术的发展,部分胃食管反流病患者可以选择接受内镜治疗或外科手术治疗。本文将对内镜下治疗技术(射频治疗、经口内镜下贲门缩窄术、抗反流黏膜切除术、内镜下胃底折叠术)及腹腔镜下胃底折叠术的研究进展进行综述。

Gastroesophageal reflux disease (GERD) is a common gastrointestinal disease, which major treatment is medication therapy, such as pump proton inhibitors (PPIs). However, PPIs are limited in GERD treatment. Therefore, with the development of endoscopic and laparoscopic techniques, patients with GERD can choose endoscopic therapies or surgeries to cure the disease. New progress in endoscopic therapies (radiofrequency therapies, peroral endoscopic cardial constriction, anti-reflux mucosectomy, endoscopic fundoplication) and laparoscopic fundoplication will be elaborated in this review.

[1]
El-Serag HB, Sweet S, Winchester CC, et al. Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review[J]. Gut, 2014, 63(6): 871-880.
[2]
Subramanian CR, Triadafilopoulos G. Refractory gastroesophageal reflux disease[J]. Gastroenterol Rep(Oxf), 2015, 3(1): 41-53.
[3]
El-Serag H, Becher A, Jones R. Systematic review: persistent reflux symptoms on proton pump inhibitor therapy in primary care and community studies[J]. Aliment Pharmacol Ther2010, 32(6): 720-737.
[4]
Ito T, Jensen RT. Association of long-term proton pump inhibitor therapy with bone fractures and effects on absorption of calcium, vitamin B12, iron, and magnesium[J]. Curr Gastroenterol Rep, 2010, 12(6): 448-457.
[5]
Lo WK, Chan WW. Proton pump inhibitor use and the risk of small intestinal bacterial overgrowth: a meta-analysis[J]. Clin Gastroenterol Hepatol, 2013, 11(5): 483-490.
[6]
Zirk-Sadowski J, Masoli JA, Delgado J, et al. Proton-pump inhibitors and long-term risk of community-acquired pneumonia in older adults[J]. J Am Geriatr Soc, 2018, 66(7): 1332-1338.
[7]
Hung YP, Lee JC, Tsai BY, et al. Risk factors of Clostridium difficile-associated diarrhea in hospitalized adults: Vary by hospitalized duration[J/OB]. J Microbiol Immunol Infect, 2019, S1684-1182(19)30088-X.
[8]
Fry LC, Mönkemüller K, Malfertheiner P. Systematic review: endoluminal therapy for gastro-oesophageal reflux disease: evidence from clinical trials[J]. Eur J Gastroenterol Hepatol, 2007, 19(12): 1125-1139.
[9]
Tam WC, Schoeman MN, Zhang Q, et al. Delivery of radiofrequency energy to the lower oesophageal sphincter and gastric cardia inhibits transient lower oesophageal sphincter relaxations and gastro-oesophageal reflux in patients with reflux disease[J]. Gut, 2003, 52(4): 479-485.
[10]
Hummel K, Richards W. Endoscopic treatment of gastroesophageal reflux disease[J]. Surg Clin North Am, 2015, 95(3): 653-667.
[11]
Viswanath Y, Maguire N, Obuobi RB, et al. Endoscopic day case antireflux radiofrequency(Stretta) therapy improves quality of life and reduce proton pump inhibitor(PPI) dependency in patients with gastro-oesophageal reflux disease: a prospective study from a UK tertiary centre[J]. Frontline Gastroenterol, 2019, 10(2): 113-119.
[12]
Liu PP, Meng QQ, Lin H, et al. Radiofrequency ablation is safe and effective in the treatment of Chinese patients with gastroesophageal reflux disease: A single-center prospective study[J]. J Dig Dis, 2019, 20(5): 229-234.
[13]
Liang WT, Wang ZG, Wang F, et al. Long-term outcomes of patients with refractory gastroesophageal reflux disease following a minimally invasive endoscopic procedure: a prospective observational study[J]. BMC Gastroenterol, 2014, 14: 178.
[14]
Noar M, Squires P, Noar E, et al. Long-term maintenance effect of radiofrequency energy delivery for refractory GERD: a decade later[J]. Surg Endosc, 2014, 28(8): 2323-2333.
[15]
Kalapala R, Shah H, Nabi Z, et al. Treatment of gastroesophageal reflux disease using radiofrequency ablation(Stretta procedure): An interim analysis of a randomized trial[J]. Indian J Gastroenterol, 2017, 36(5): 337-342.
[16]
Coron E, Sebille V, Cadiot G, et al. Clinical trial: Radiofrequency energy delivery in proton pump inhibitor-dependent gastro-oesophageal reflux disease patients[J]. Aliment Pharmacol Ther, 2008, 28(9): 1147-1158.
[17]
He S, Xu F, Xiong X, et al. Stretta procedure versus proton pump inhibitors for the treatment of nonerosive reflux disease: A 6-month follow-up[J]. Medicine(Baltimore), 2020, 99(3): e18610.
[18]
Perry KA, Banerjee A, Melvin WS. Radiofrequency energy delivery to the lower esophageal sphincter reduces esophageal acid exposure and improves GERD symptoms: a systematic review and meta-analysis[J]. Surg Laparosc Endosc Percutan Tech, 2012, 22(4): 283-288.
[19]
Fass R, Cahn F, Scotti DJ, et al. Systematic review and meta-analysis of controlled and prospective cohort efficacy studies of endoscopic radiofrequency for treatment of gastroesophageal reflux disease[J]. Surg Endosc, 2017, 31(12): 4865-4882.
[20]
Lipka S, Kumar A, Richter JE. No evidence for efficacy of radiofrequency ablation for treatment of gastroesophageal reflux disease: a systematic review and meta-analysis[J]. Clin Gastroenterol Hepatol, 2015, 13(6): 1058-1067. e1.
[21]
Triadafilopoulos G. Stretta: a valuable endoscopic treatment modality for gastroesophageal reflux disease[J]. World J Gastroenterol, 2014, 20(24): 7730-7738.
[22]
Li X, Zhang XB, Hu HQ, et al. Effect and safety of peroral endoscopic cardial constriction for gastroesophageal reflux disease[J]. Chin Med J(Engl), 2017, 130(14): 1749-1750.
[23]
Hu HQ, Li HK, Xiong Y, et al. Peroral endoscopic cardial constriction in gastroesophageal reflux disease[J]. Medicine (Baltimore), 2018, 97(15): e0169.
[24]
Satodate H, Inoue H, Yoshida T, et al. Circumferential EMR of carcinoma arising in Barrett's esophagus: case report[J]. Gastrointest Endosc, 2003, 58(2): 288-292.
[25]
Patil G, Dalal A, Maydeo A. Feasibility and outcomes of anti-reflux mucosectomy for proton pump inhibitor dependent gastroesophageal reflux disease: First Indian study(with video)[J]. Dig Endosc, 2020, 32(5): 745-752.
[26]
Inoue H, Ito H, Ikeda H, et al. Anti-reflux mucosectomy for gastroesophageal reflux disease in the absence of hiatus hernia: a pilot study[J]. Annals of gastroenterology, 2014, 27(4): 346-351.
[27]
Sumi K, Inoue H, Kobayashi Y, et al. Endoscopic treatment of proton pump inhibitor-refractory gastroesophageal reflux disease with anti-reflux mucosectomy: Experience of 109 cases[J]. Dig Endosc, 2020, DOI: 10.1111/den.13727.
[28]
Trad KS, Barnes WE, Prevou ER, et al. The TEMPO Trial at 5 Years: Transoral Fundoplication(TIF 2.0) Is Safe, Durable, and Cost-effective[J]. Surg Innov, 2018, 25(2): 149-157.
[29]
Testoni PA, Testoni S, Distefano G, et al. Transoral incisionless fundoplication with EsophyX for gastroesophageal reflux disease: clinical efficacy is maintained up to 10 years[J]. Endosc Int Open, 2019, 7(5): E647-E654.
[30]
Zacherl J, Roy-Shapira A, Bonavina L, et al. Endoscopic anterior fundoplication with the Medigus Ultrasonic Surgical Endostapler (MUSE) for gastroesophageal reflux disease: 6-month results from a multi-center prospective trial[J]. Surg Endosc, 2015, 29(1): 220-229.
[31]
Kim HJ, Kwon CI, Kessler WR, et al. Long-term follow-up results of endoscopic treatment of gastroesophageal reflux disease with the MUSE endoscopic stapling device[J]. Surg Endosc, 2016, 30(8): 3402-3408.
[32]
Richards WO, Houston HL, Torquati A, et al. Paradigm shift in the management of gastroesophageal reflux disease[J]. Ann Surg, 2003, 237(5): 638-647.
[33]
Liang WT, Wu JM, Hu ZW, et al. Laparoscopic Nissen fundoplication is more effective in treating patients with GERD-related chronic cough than Stretta radiofrequency[J]. Minerva Chir, 2014, 69(3): 121-127.
[34]
Hu ZW, Wang ZG, Zhang Y, et al. A preliminary investigation of anti-reflux intervention for gastroesophageal reflux related childhood-to-adult persistent asthma[J]. Ann Surg Innov Res, 2014, 8: 3.
[35]
Liang WT, Wu JN, Wang F, et al. Five-year follow-up of a prospective study comparing laparoscopic Nissen fundoplication with Stretta radiofrequency for gastroesophageal reflux disease[J]. Minerva Chir, 2014, 69(4): 217-223.
[36]
Liang WT, Yan C, Wang ZG, et al. Early and Midterm outcome after laparoscopic fundoplication and a minimally invasive endoscopic procedure in patients with gastroesophageal reflux disease: a prospective observational Study[J]. J Laparoendosc Adv Surg Tech A, 2015, 25(8): 657-661.
[37]
Hu Z, Wu J, Wang Z, et al. Outcome of Stretta radiofrequency and fundoplication for GERD-related severe asthmatic symptoms[J]. Front Med, 2015, 9(4): 437-443.
[38]
Yan C, Liang WT, Wang ZG, et al. Comparison of Stretta procedure and toupet fundoplication for gastroesophageal reflux disease-related extra-esophageal symptoms[J]. World J Gastroenterol, 2015, 21(45): 12882-12887.
[39]
Zhang C, Wu J, Hu Z, et al. Diagnosis and anti-reflux therapy for gerd with respiratory symptoms: a study using multichannel intraluminal impedance-pH monitoring[J]. PLoS One, 2016, 11(8): e0160139.
[1] 邢益民, 张天飞, 戴慧勇. 胃肠充盈超声造影检查在反酸、嗳气患者临床诊断中的应用[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(03): 303-306.
[2] 李海云, 赵敏娴, 申英末, 杨慧琪. 胃底折叠术预防食管裂孔疝术后并发症的研究进展[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(05): 485-490.
[3] 玉素江·图荪托合提, 韩琦, 麦麦提艾力·麦麦提明, 黄旭东, 王浩, 克力木·阿不都热依木, 艾克拜尔·艾力. 腹腔镜袖状胃切除或联合食管裂孔疝修补术对肥胖症合并胃食管反流病的中期疗效分析[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(05): 501-506.
[4] 任传富, 杨志, 徐恩, 何梓芸, 罗板鑫, 陈新, 夏雪峰. 腹腔镜疝修补术联合胃底折叠术治疗食管裂孔疝合并胃食管反流病40 例临床分析[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(05): 507-511.
[5] 胡志伟, 吴继敏, 汪忠镐, 张美光. 胃食管反流病食管外症状抗反流手术适应证及术前评估[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(03): 241-246.
[6] 胡志伟, 吴继敏, 邓昌荣, 战秀岚, 纪涛, 王峰, 田书瑞, 陈冬, 张玉, 刘健男, 宋庆. 抗反流黏膜套扎治疗顽固性胃食管反流病[J/OL]. 中华腔镜外科杂志(电子版), 2024, 17(04): 227-233.
[7] 孙武青, 郭震, 郝少龙, 孙海涛, 姬阆, 白日星, 韩威. LSG中保留胃窦部及His角完整性对术后胃食管反流病的影响[J/OL]. 中华腔镜外科杂志(电子版), 2024, 17(02): 95-99.
[8] 唐小久, 胡曼, 许必君, 肖亚. 肥胖合并胃食管反流病患者严重程度与其焦虑抑郁及营养状态的相关性研究[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(04): 360-364.
[9] 张静, 白亦冰, 来要良, 刘永, 和媛媛, 苏敏. 不同体位对胃食管反流病患者食管高分辨率测压的影响[J/OL]. 中华胃食管反流病电子杂志, 2024, 11(03): 115-120.
[10] 张靖, 柏君, 陈玉盟, 张鹏, 侯芳芳, 王军芳, 孙静, 赵士博, 杨喆, 张玥, 张瑞芳, 朱宏斌. 抗反流黏膜消融术治疗胃食管反流病患者的临床疗效[J/OL]. 中华胃食管反流病电子杂志, 2024, 11(03): 121-125.
[11] 华丽, 仲卫冬, 胡根, 张丽英, 邵国益. 手术治疗胃食管反流病对患者生活质量和心理状态影响的研究[J/OL]. 中华胃食管反流病电子杂志, 2024, 11(03): 126-129.
[12] 文明, 张丽, 谢芳, 艾克拜尔·艾力, 克力木·阿不都热依木. 构建胃食管反流病患者发生心房颤动的临床预测模型[J/OL]. 中华胃食管反流病电子杂志, 2024, 11(03): 130-136.
[13] 高训锋, 许晓露, 张金辉, 蔡理全, 张恒, 邰沁文. 胃食管反流病与肝胆胰系统疾病的因果关系:一项孟德尔随机化研究[J/OL]. 中华胃食管反流病电子杂志, 2024, 11(03): 143-152.
[14] 刘虎, 任振, 韦笑韩, 潘晨, 吴立胜. 胃食管反流伴食管运动障碍的诊疗进展[J/OL]. 中华胃食管反流病电子杂志, 2024, 11(03): 153-158.
[15] 中国医师协会外科医师分会肥胖和代谢病外科专家工作组, 中国医师协会外科医师分会胃食管反流疾病诊疗外科专家工作组, 日本肥胖治疗学会, 韩国减重与代谢外科学会. 袖状胃切除术患者胃食管反流病诊治专家共识(2024版)[J/OL]. 中华肥胖与代谢病电子杂志, 2024, 10(03): 145-162.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?